Lyvgen Biopharma, a leading innovative global biotech company dedicated to discovering, developing and commercializing first-in-class and best-in-class biotherapeutics for cancer, announced an open label,...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced that it has entered into an evaluation and option agreement with ADC Therapeutics SA. Biocytogen will grant ADC...
Alcami, a leading contract development and manufacturing organization (CDMO), announced the completion of Phase II of its cGMP biostorage facility located in Amherst, New...
